Cancer Biomarkers Market Is Expected To Growing At A CAGR Of 14.3% During Forecast Period 2014-2025

Global Cancer Biomarkers Market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.

People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.

Access Full Research Report on Global Cancer Biomarkers Market Analysis: http://www.grandviewresearch.com/industry-analysis/cancer-biomarker-market

Further Key findings from the study suggest:

• Breast cancer was the largest segment by revenue share in 2016 owing to high prevalence of this type of cancer
• Lung cancer is estimated to be the fastest-growing type due to increasing research activities toward development of novel lung cancer biomarkers
• Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016
• However, epigenetic biomarkers are anticipated to witness lucrative growth due to increasing focus on finding the role of epigenetic modifications in cancer development
• Cancer biomarkers are majorly used for diagnostic purpose owing to their high specificity
• The personalized medicine segment is estimated to witness fastest CAGR of 15.0% over the forecast period
• North America dominated in terms of revenue share in 2016 due to established R&D infrastructure and high acceptance of biomarker-based cancer testing in this region
• Asia Pacific is anticipated to grow at a substantial growth rate till 2025 with CAGR of over 16.7%
• Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Cancer Biomarkers Market by type, biomolecule, applications, and region:

Cancer Biomarker Type Outlook (Revenue, USD Billion, 2014 - 2025)

• Breast cancer
• Prostate cancer
• Colorectal cancer
• Cervical cancer
• Liver cancer
• Lung cancer
• Others

Cancer Biomarker Biomolecule Outlook (Revenue, USD Billion, 2014 - 2025)

• Genetic Biomarkers
• Epigenetic Biomarkers
• Metabolic Biomarkers
• Proteomic Biomarkers
• Others

Cancer Biomarker Application Outlook (Revenue, USD Billion, 2014 - 2025)

• Drug discovery and Development
• Diagnostics
• Personalized medicine
• Others

Cancer Biomarker Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• Latin America
• Mexico
• Brazil
• MEA
• South Africa

View Blog On this research report by Grand View Research: http://www.grandviewresearch.com/blog/cancer-biomarker-market-insight-size-share

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Capsule Endoscopy Market Is Projected To Grow At A CAGR Of 8.7% Over The Forecast Period 2012-2022

Global Capsule Endoscopy Market is expected to reach USD 886.3 million by 2022; according to a new study by Grand View Research, Inc. increasing prevalence of colorectal cancer, GI diseases and growing demand for precise and accurate diagnostic tools are expected to drive the capsule endoscopy market over the forecast period. According to a report published by the World Cancer Research Institute, about 54.0% of colorectal cancer cases occurred in developed countries and the number is expected to grow exponentially over the decade. 

The introduction of technologically advanced features such as WiFi enabled small bowel capsules featuring longer battery life are further expected to drive the demand for capsule endoscopy devices. Presence of favorable government initiatives are expected to play an imperative role in determining market trends over the forecast period. For instance, initiatives such as the DCPC’s National Comprehensive Cancer Control Program (NCCCP) in the U.S. aimed at increasing patient awareness levels pertaining to colorectal cancer screening is expected to boost usage rates during the forecast period.

Full Research Report on Global Capsule Endoscopes Market Analysis:http://www.grandviewresearch.com/industry-analysis/capsule-endoscopes-market

Further key findings from the study suggest:

• Wireless capsules dominated the accessory market in 2014 and are also expected to register lucrative growth over the forecast period. Increasing usage rates of colon, small intestine and esophageal screening is expected to drive segment growth. In addition, presence of supportive reimbursement policies and the introduction of technologically advanced products are expected to serve this market as future growth opportunities.
• Small bowel endoscopy capsule was the leading product segment of the market in 2014. These devices find wide applications in treating diseases such as suspected Crohn’s disease, inflammatory bowel disease, obscure GI tract bleeding and small bowel neoplastic lesions and this is expected to serve the segment as a high impact rendering driver. Increasing prevalence of target diseases is also expected to make significant contributions towards market growth.
• Capsule endoscopy finds the largest application in OGIB (Obscure gastrointestinal bleeding) diagnosis owing to, increasing usage of wireless capsule endoscopes in vascular and inflammatory lesion diagnoses
• North America was the largest regional capsule endoscopy market in 2014. The region’s market position is attributed to by factors such as presence of sophisticated healthcare infrastructure, supportive reimbursement policies and growing adoption rates of minimally invasive surgeries.
• Asia Pacific region is anticipated to register rapid growth over the forecast period owing to, factors such as the presence of high unmet needs with respect to colorectal screening, rising disposable income and patient awareness levels and improving healthcare infrastructure
• Key market players of the capsule endoscopy market include RF System lab, Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Given Imaging, Ltd., Fujifilm Holding Corporation, IntroMedic Co., Ltd and CapsoVision.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

For the purpose of this study, Grand View Research has segmented the Global Capsule 

Endoscopy Market on the basis of accessory, product, application and region:

• Global Capsule Endoscopy Accessories Outlook (Revenue, USD Million, 2012 - 2022)
• Wireless capsule
• Workstation and receiver
• Global Capsule Endoscopy Product Outlook (Revenue, USD Million, 2012 - 2022)
• Small bowel
• Esophageal
• Colon
• Global Capsule Endoscopy Application Outlook (Revenue, USD Million, 2012 - 2022)
• OGIB
• Crohn’s disease
• Small Intestine tumor
• Others (Celiac, NSAID reactions)
• Capsule Endoscopy Regional Outlook (Revenue, USD Million, 2014 - 2022)
• North America

§  U.S.

§  Canada

·         Europe

§  Germany

§  UK

·         Asia Pacific

§  China

§  Japan

·         Latin America

§  Mexico

§  Brazil

·         MEA

§  South Africa

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-capsule-endoscopy-market   

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Lactoferrin Market Is Estimated To Grow At A CAGR Of 8.4% During Forecast Period 2014-2025

Global Lactoferrin Market is expected to reach USD 167.9 million by 2025, according to a new report by Grand View Research, Inc. Increasing demand for infant formula has been a major factor driving market growth. Utilization of lactoferrin has increased owing to the rising health concerns among consumers.

Lactoferrin is derived from the transferrin family and is a multifunctional protein. Transferrins are glycoproteins and are known to have the ability to control the free iron content in the human body, and bind them together. The transferrin family derivative is present in extensive quantities in various parts of the human body including, tears, nasal secretions, milk, and saliva.

The multifunctional protein helps to separate the free iron in the human body and also remove any content which promotes bacterial activity. The transferring family derivative helps to inhibit the bacterial growth by binding the lipopolysaccharides with bacterial walls and thus forming peroxides. Owing to this ability of the multifunctional protein, it is widely used in the healthcare sector for curing and preventing bacterial infections & diseases. The antibacterial function of lactoferrin is projected to show a high growth over the next eight years. The antibacterial function segment had a market share of 20.4% in 2016.

Infant formula application segment is expected to have a steady growth rate over the next eight years with an estimated CAGR of 8.1%. The multifunctional protein is the key component of human milk required for infants as they help in iron absorption and its transportation. Cow’s milk contains the multifunctional protein in minute quantities of 0.1 mg/mL, whereas infants require it in the quantities of 2-3 mg/mL. Commercially produced infant formula with lactoferrin content has high iron absorption, antibacterial, and antioxidation properties. This factor is projected to propel the infant formula segment growth over the next eight years.

Full Research Report on Global Lactoferrin Market Analysis:
http://www.grandviewresearch.com/industry-analysis/lactoferrin-market

Further key findings from the report suggest:

• The global lactoferrin demand was 255.0 tons in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
• Iron absorption emerged as the largest function segment in 2016 and is estimated to be worth 151.9 tons by 2025
• Intestinal flora protection is anticipated to be the fastest growing function segment over the next eight years and is estimated to grow at a CAGR of 8.7%
• The global lactoferrin demand in food & beverages application was valued at USD 19.7 million in 2016 and is anticipated to witness steady growth over the next eight years
• Industry participants include Metagenics, Pharming Group N.V., Vitalus Nutrition Inc., Ingredia SA., MP Biomedicals, Glanbia Nutritionals, Farbest Brands, Fonterra Co-Operative Group Ltd., and ProHealth

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the Global Lactoferrin Market on the basis of function, application, and region:

Lactoferrin Function Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)

• Iron absorption
•  Anti-inflammatory
•  Intestinal flora protection
•  Antibacterial
•  Immune cell stimulation
•  Antioxidant

Lactoferrin Application Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)

• Food & beverages
• Infant formula
• Sports & functional food
• Animal feed
• Pharmaceuticals
• Personal care products

Lactoferrin Regional Outlook (Revenue, USD Million; Volume Tons, 2014 - 2025)

• North America
• U.S.
• Europe
• UK
• Germany
• Asia Pacific
• China
• Japan
• Central & South America
• Middle East & Africa

View Press Release Of This Research Report By Grand View Research: 

http://www.grandviewresearch.com/press-release/global-lactoferrin-market     

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Catheters Market Is Expected To Grow At A CAGR Of 9.7% From 2014 To 2020

Global Catheters Market is expected to reach USD 46.05 billion by 2020, according to a new report by Grand View Research. Key factors driving the market growth include growing prevalence of obesity, diabetes and cardiovascular diseases and rising demand for minimally invasive procedures. Introduction of advanced catheters with improved efficacies and increasing number of minimally invasive procedures in emerging Asian markets such as China and India are expected to support the market growth.

Research improvements in clinical trials to inhibit the growth of bio-film development on urinary catheter and introduction of hydrophilic coatings for catheter based delivery systems is anticipated to upsurge the demand of novel catheters for various surgical procedures. Furthermore, growth in the global geriatric population, which is highly prone to infectious diseases, is also expected to attribute towards the industry growth.

Access Full Research Report on Global Catheters Market: http://www.grandviewresearch.com/industry-analysis/catheters-market-analysis

Unhealthy lifestyle habits such as excessive smoking, alcohol consumption and medical conditions like diabetes that consequently widens the consumer base by facilitating the need for catheter in surgical procedures, is anticipated to significantly boost the usage rate.

Cardiovascular catheters is estimated to account for the largest share in 2013 over 39.0% owing to the introduction of technologically advanced devices and high acceptance of this catheter in cardiac interventional procedures such as angiography and angioplasty.

However, specialty segment is expected to witness significant gains with the CAGR over 12.0% during the forecast period due to the presence of advance product portfolio that meet the needs of wide spectrum of urological applications such as Foley catheter.

Europe is expected to account for nearly 40% of the global revenue generated in 2020 owing to the presence of favorable government initiatives and a sophisticated healthcare infrastructure.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Asia Pacific is expected to witness the highest growth at a CAGR of 14.3% over the forecast period owing to novel products development and improving healthcare infrastructure in the region during the forecast period.

Key players of the catheter market include Boston Scentific Corporation, Abbott Laboratories, Johnson & Johnson, C.R Bard, Convatech, Cure Medical, Stryker Corporation, and Covidien. Constant research activities conducted in R&D departments and introduction of novel products such as NC Euphora Noncomplaint Balloon Dilation and collaboration with the International Diabetes Federation by Medtronic Inc, account for some of key strategic initiatives implemented by the major players.

View Press Release On Global Catheters Market By Grand View Research: http://www.grandviewresearch.com/press-release/global-catheters-market         

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cell Isolation Market Is Projected To Grow At 18.6% Over The Forecast Period 2014-2025

Global Cell Separation/Cell Separation Market is expected to reach a value of USD 16.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for biopharmaceuticals including antibodies, proteins, vaccines, and drugs is the most important factor that drives the market growth during the forecast period. Biopharmaceuticals development involves the application of various life science products such as centrifuges, cell separator systems, flow cytometers, filtration systems, and consumables. Thus, the demand for advanced cell isolation products by biotechnology and biopharmaceutical companies is increasing, which is expected to boost the market growth.

Rising funding by biotechnology companies and government for cell-based research is another major factor driving the growth of the cell isolation/cell separation market. For instance, National Institutes of Health invested around USD 1,429 million for stem cells research in 2015. Stem cell therapy is the most promising technique to treat severe medical conditions such as cancer, cardiovascular disease, brain disease, and blood disease. Thus, the biotechnology companies are adopting advanced cell separation products for the research and development of stem cells.

Full Research Report on Global Cell Isolation Market: http://www.grandviewresearch.com/industry-analysis/cell-isolation-cell-separation-market

Further key findings from the study suggest:

• Consumables product segment was the largest revenue-generating segment of the market in the year 2016.
• Consumables is expected to uphold its dominance during the forecast period owing to repetitive purchase of these products for research and diagnostics application
• The human cells segment was the largest revenue grossing segment of the sector in 2016, and is expected to grow at fastest rate due to growing demand of isolated human cell in therapeutics, research, and biopharmaceuticals production
• In 2016, the centrifugation technique segment accounted for the largest share in the overall market, owing to its wide application for manufacturing of biopharmaceutical drugs, vaccines, proteins, and antibodies
• In 2016, North America dominated the overall market with the largest revenue share due to the existence of major biopharmaceutical companies and research laboratories in this region
• Asia Pacific is projected to witness the highest CAGR over the forecast period, owing to the mounting investments in cell-based research and rapidly booming biotechnology industry in this region
• Some of the key players include Thermo Fisher Scientific, Inc.; BD Biosciences; GE Healthcare; Beckman Coulter, Inc.; Merck KGaA; Terumo BCT; STEMCELL Technologies Inc.; and Bio-Rad Laboratories, Inc.

Browse More Reports From Same Category: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Cell Separation Market on the basis of product, cell type, technique, application, end-use, and region:

Cell Isolation Product Outlook (Revenue, USD Million; 2014 - 2025)

• Consumables
• Reagents, kits, media, and sera
• Beads
• Disposables
• Instruments
• Centrifuges
• Flow cytometers
• Filtration systems
• Magnetic-activated cell separator systems

Cell Isolation Type Outlook (Revenue, USD Million; 2014 - 2025)

• Human cells
• Animal cells

Cell Separation Technique Outlook (Revenue, USD Million; 2014 - 2025)

• Centrifugation
• Surface marker
• Filtration

Cell Isolation Application Outlook (Revenue, USD Million; 2014 - 2025)

• Biomolecule isolation
• Therapeutics
• Stem cell research
• Cancer research
• Tissue regeneration
• In-vitro diagnostics

Cell Isolation End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Research laboratories and institutes
• Biotechnology and biopharmaceutical companies
• Cell banks
• Hospitals and diagnostic laboratories

Cell Isolation Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Blog on Cell Isolation/Cell Separation Market By Grand View Research: http://www.grandviewresearch.com/blog/cell-isolation-cell-separation-market-size-share

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Cardiac Biomarkers Market Is Segmented On The Basis Of Type, Application, End Use, And Region 2013-2024

Cardiac Biomarkers Market is expected to reach USD13.3 billion by 2024, according to a new report by Grand View Research, Inc. The cardiac biomarkers market is anticipated to witness a lucrative growth during the forecast period from 2016 to 2024. Analysis of global market trends focuses on the increasing demand for cardiac biomarkers owing to its increased adoption in cardiovascular disease diagnosis. Furthermore, this growth is attributed to a majority of factors, such as the high prevalence of Acute Coronary Syndrome (ACS), continual technological advancements in the development of cardiovascular biomarkers, increasing number of new product launches by the key market players, rising demand for point of care cardiac testing kits, along with the high specificity and sensitivity of these biomarkers in the detection of cardiovascular diseases, especially acute myocardial infarction.

The cardiac biomarkers market has been classified by type into troponin, Creatine kinase-MB(CK-MB), B-type Natriuretic Peptide (BNP), and N-terminal pro b-type natriuretic peptide (NT-proBNP), myoglobin, and others. Troponin is a heteromeric protein and comprises cardiac troponin T & I, which are abbreviated as cTnT & cTnI, respectively. The troponin biomarkers segment is expected to grow lucratively in the forecast period at a significant CAGR. The diagnostic efficiency and specificity related to cardiac biomarker testing renders it a universally gold standard test to diagnose cardiovascular disorders worldwide. The market by application is segmented into acute coronary syndrome, myocardial infarction, congestive heart failure, and others. ACS is expected to be the highest grossing segment according to the study. ACS is responsible for huge medical costs globally and is responsible for most hospital readmission cases. The increasing efforts to cut down worldwide ACS prevalence rates are expected to drive the growth of the biomarkers market.

The key countries included in the report are U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa, and the Middle East. North America accounted for the largest market in 2015, whereas the Asia Pacific region is anticipated to be the fastest growing region during the forecast period.

Full Research Report on Global Cardiac Bio-makers Market: http://www.grandviewresearch.com/industry-analysis/cardiac-biomarker-market

Further key findings from the study suggest:

• North America is estimated to dominate the global cardiac biomarkers market. The high prevalence of coronary heart disease in western countries is one of the major factors contributing to the high demand for cardiac biomarker diagnostics.
• The Asia Pacific region is anticipated to be the fastest growing region in the study period owing to the large population, especially in China and India. Apart from that, there exists a high prevalence rate of myocardial infarction in the region. This prevalence rate is expected to fuel the demand for cardiac biomarker diagnostics.
• The troponin biomarker segment is expected to grow at a significant rate, and is expected to grow at the highest CAGR compared to others and accounts for the largest market share in 2015.
• The sector comprises of several local as well as global players. Some of the major players of this vertical include Alere, Inc., Siemens Healthcare GmbH, Roche Diagnostics, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, and bioMerieux SA.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Global Cardiac Biomarkers Market on the basis of type, application, end use, and region:

Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2013 - 2024)

• Troponin
• CK-MB
• Natriuretic peptides - BNP and NT-proBNP
• Myoglobin
• Others

Cardiac Biomarkers Market Application Outlook (Revenue, USD Million, 2013 - 2024)

• Acute Coronary Syndrome
• Myocardial infarction
• Congestive heart failure
• Others

Cardiac Biomarkers Market End-use Outlook (Revenue, USD Million, 2013 - 2024)

• Laboratory Testing
• Point of Care Testing

Cardiac Biomarkers Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Middle East

View Press Release On This Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiac-biomarker-market      

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Carcinoembryonic Antigen Market Analysis By Application And Segment Forecast Up To 2022

Global Carcinoembryonic Antigen Market is expected to reach USD 2.56 Billion by 2022, according to a new study by Grand View Research, Inc. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. 

Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth. 

Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.

Full Research Report on Global Carcinoembryonic Antigen (CEA) Market Analysis:  http://www.grandviewresearch.com/industry-analysis/carcinoembryonic-antigen-cea-market

Further key findings from the study suggest:

• Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.
• Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above 50 years, growing demand for Hormone Replacement Therapy (HRT) and cosmetic surgeries. Moreover, growing patient awareness levels and the presence of favorable government initiatives are expected to improve treatment rates over the forecast period.
• North America was the largest regional market in 2014 owing to, the presence of high incidence rates, presence of favorable reimbursement framework, and high consumer awareness levels coupled with relatively higher healthcare expenditure levels.
• Asia Pacific is anticipated to witness the most lucrative growth over the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, economic development, and improving patient awareness levels are some factors accounting for this rapid growth.
• Key players operating in carcinoembryonic antigen market include Abbott Diagnostics, Quest Diagnostics, Roche Diagnostics, GenWay Biotech Inc. and Correlogic Systems, Inc. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

For the purpose of this study, Grand View Research has segmented the Global 

Carcinoembryonic Antigen Market on the basis of application, and region:

Carcinoembryonic Antigen Application Outlook (Revenue, USD Million, 2012 - 2022)

• Colorectal cancer
• Pancreatic cancer
• Ovarian cancer
• Breast cancer
• Thyroid cancer
• Others

Carcinoembryonic Antigen Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
• U.S.
• Canada

• Europe
• Germany
• France
• Spain
• Asia Pacific
• China
• Japan
• India
• MEA
• South Africa
• Latin America
• Brazil
• Mexico

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology                             

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com